
Director of Cellular Longevity
Dr. Elena Vance
MD, PhD | Harvard Medical School
Pioneer in cellular senescence and longevity science. Directs our advanced epigenetic reprogramming and molecular protocols.
Clinical Focus
Cellular Senescence Mitigation
Epigenetic Reprogramming
Molecular System Optimization
Telomere Attrition Prevention
Board Certifications
American Board of Internal Medicine
Fellowship in Regenerative and Longevity Medicine, Harvard
Alpha Omega Alpha Honor Medical Society
Pioneering Research
Lead Author: "Reversal of Vascular Aging via Epigenetic Remodeling" (Nature Medicine, 2024)
Co-Investigator: "Senolytic Clearance and Longitudinal Healthspan Dynamics" (Cell Metabolism, 2025)